Buchumschlag

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic

AbstractBackground. Treatment with immune checkpoint blockade (ICB) with agents such as anti-programmed cell death protein 1 (PD-1), anti-programmed death-liga

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Chan, Timothy A. (VerfasserIn) , Yarchoan, M. (VerfasserIn) , Jaffee, E. (VerfasserIn) , Swanton, C. (VerfasserIn) , Quezada, S. A. (VerfasserIn) , Stenzinger, Albrecht (VerfasserIn) , Peters, S. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2019
In: Annals of oncology
Year: 2018, Jahrgang: 30, Heft: 1, Pages: 44-56
ISSN:1569-8041
DOI:10.1093/annonc/mdy495
Online-Zugang:Verlag, Volltext: https://doi.org/10.1093/annonc/mdy495
Verlag, Volltext: https://academic.oup.com/annonc/article/30/1/44/5160130
Volltext
Verfasserangaben:T.A. Chan, M. Yarchoan, E. Jaffee, C. Swanton, S.A. Quezada, A. Stenzinger & S. Peters

MARC

LEADER 00000caa a2200000 c 4500
001 1667902911
003 DE-627
005 20220816174437.0
007 cr uuu---uuuuu
008 190625r20192018xx |||||o 00| ||eng c
024 7 |a 10.1093/annonc/mdy495  |2 doi 
035 |a (DE-627)1667902911 
035 |a (DE-599)KXP1667902911 
035 |a (OCoLC)1341230097 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Chan, Timothy A.  |e VerfasserIn  |0 (DE-588)1189171171  |0 (DE-627)1667903489  |4 aut 
245 1 0 |a Development of tumor mutation burden as an immunotherapy biomarker  |b utility for the oncology clinic  |c T.A. Chan, M. Yarchoan, E. Jaffee, C. Swanton, S.A. Quezada, A. Stenzinger & S. Peters 
264 1 |c 2019 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published: 05 November 2018 
500 |a Gesehen am 25.06.2019 
520 |a AbstractBackground. Treatment with immune checkpoint blockade (ICB) with agents such as anti-programmed cell death protein 1 (PD-1), anti-programmed death-liga 
534 |c 2018 
700 1 |a Yarchoan, M.  |e VerfasserIn  |4 aut 
700 1 |a Jaffee, E.  |e VerfasserIn  |4 aut 
700 1 |a Swanton, C.  |e VerfasserIn  |4 aut 
700 1 |a Quezada, S. A.  |e VerfasserIn  |4 aut 
700 1 |a Stenzinger, Albrecht  |e VerfasserIn  |0 (DE-588)139606106  |0 (DE-627)703395238  |0 (DE-576)312432755  |4 aut 
700 1 |a Peters, S.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Annals of oncology  |d Amsterdam [u.a.] : Elsevier, 1990  |g 30(2019), 1, Seite 44-56  |h Online-Ressource  |w (DE-627)320428796  |w (DE-600)2003498-2  |w (DE-576)098134345  |x 1569-8041  |7 nnas  |a Development of tumor mutation burden as an immunotherapy biomarker utility for the oncology clinic 
773 1 8 |g volume:30  |g year:2019  |g number:1  |g pages:44-56  |g extent:13  |a Development of tumor mutation burden as an immunotherapy biomarker utility for the oncology clinic 
856 4 0 |u https://doi.org/10.1093/annonc/mdy495  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://academic.oup.com/annonc/article/30/1/44/5160130  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190625 
993 |a Article 
994 |a 2019 
998 |g 139606106  |a Stenzinger, Albrecht  |m 139606106:Stenzinger, Albrecht  |d 910000  |d 912000  |e 910000PS139606106  |e 912000PS139606106  |k 0/910000/  |k 1/910000/912000/  |p 6 
999 |a KXP-PPN1667902911  |e 3489636813 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1667902911"],"doi":["10.1093/annonc/mdy495"]},"physDesc":[{"extent":"13 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"subtitle":"utility for the oncology clinic","title":"Development of tumor mutation burden as an immunotherapy biomarker","title_sort":"Development of tumor mutation burden as an immunotherapy biomarker"}],"origin":[{"dateIssuedDisp":"2019","dateIssuedKey":"2019"}],"relHost":[{"recId":"320428796","origin":[{"dateIssuedDisp":"1990-","publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford","dateIssuedKey":"1990"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1569-8041"],"eki":["320428796"],"zdb":["2003498-2"]},"title":[{"subtitle":"official journal of the European Society for Medical Oncology","title":"Annals of oncology","title_sort":"Annals of oncology"}],"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"pubHistory":["1.1990 -"],"part":{"text":"30(2019), 1, Seite 44-56","pages":"44-56","extent":"13","issue":"1","year":"2019","volume":"30"},"language":["eng"],"disp":"Development of tumor mutation burden as an immunotherapy biomarker utility for the oncology clinicAnnals of oncology","type":{"bibl":"periodical","media":"Online-Ressource"},"corporate":[{"display":"European Society for Medical Oncology","role":"isb"}]}],"name":{"displayForm":["T.A. Chan, M. Yarchoan, E. Jaffee, C. Swanton, S.A. Quezada, A. Stenzinger & S. Peters"]},"language":["eng"],"note":["Published: 05 November 2018","Gesehen am 25.06.2019"],"person":[{"display":"Chan, Timothy A.","given":"Timothy A.","family":"Chan","role":"aut"},{"family":"Yarchoan","role":"aut","display":"Yarchoan, M.","given":"M."},{"given":"E.","display":"Jaffee, E.","family":"Jaffee","role":"aut"},{"given":"C.","display":"Swanton, C.","family":"Swanton","role":"aut"},{"given":"S. A.","display":"Quezada, S. A.","family":"Quezada","role":"aut"},{"role":"aut","family":"Stenzinger","given":"Albrecht","display":"Stenzinger, Albrecht"},{"display":"Peters, S.","given":"S.","family":"Peters","role":"aut"}],"recId":"1667902911"} 
SRT |a CHANTIMOTHDEVELOPMEN2019 

Ähnliche Einträge